CIK 0001712762 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
bioAffinity Technologies, Inc.
Sign in to watch- Ticker
- BIAF
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465211056
- Phone
- 210-698-5334
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
- Former names
- bioAffinity Technologies, Inc.
Securities
- BIAF Common Stock Nasdaq
- BIAFW Warrant Nasdaq
- EFFECT Other Notice of Effectiveness
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- S-1 Offering Registration Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award Executive Chairman acquired 39,474 shares (grant or award)
- 4 Option exercise Director acquired 64,848 shares (option exercise)
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
Page 13 of 21 · 401 filings